OBJECTIVES: Mutations in the APC, NF2 and BRCA1 genes cause adult-onset cancer predisposition syndromes. Prenatal diagnosis (PND) and selective pregnancy termination for adult-onset disorders is emotionally difficult and, in some cases, socially not well accepted. Preimplantation genetic diagnosis (PGD) appears as an attractive alternative to PND, as it ensures the establishment of a pregnancy free of the mutation from the onset, circumventing the potentially difficult decision of termination of pregnancy. METHODS: Development of single-cell PCRs using Epstein-Barr virus transformed lymphoblasts as single-cell model, followed by clinical application in PGD. RESULTS: A total of five duplex-PCRs were developed, three for adenomatous polyposis of the colon (APC), one for neurofibromatosis type 2 (NF2) and one for inherited breast and ovarian cancer caused by BRCA1 mutations. Eleven clinical cycles were performed, resulting in the birth of an unaffected girl. For one of the couples undergoing PGD for NF2, a spontaneous pregnancy ensued after five unsuccessful PGD cycles. The couple underwent chorionic villus sampling (CVS) and the application of the same protocol as used during PGD showed an unaffected fetus. CONCLUSION: In this work, we present the development and clinical application of PGD for three cancer predisposition syndromes.
OBJECTIVES: Mutations in the APC, NF2 and BRCA1 genes cause adult-onset cancer predisposition syndromes. Prenatal diagnosis (PND) and selective pregnancy termination for adult-onset disorders is emotionally difficult and, in some cases, socially not well accepted. Preimplantation genetic diagnosis (PGD) appears as an attractive alternative to PND, as it ensures the establishment of a pregnancy free of the mutation from the onset, circumventing the potentially difficult decision of termination of pregnancy. METHODS: Development of single-cell PCRs using Epstein-Barr virus transformed lymphoblasts as single-cell model, followed by clinical application in PGD. RESULTS: A total of five duplex-PCRs were developed, three for adenomatous polyposis of the colon (APC), one for neurofibromatosis type 2 (NF2) and one for inherited breast and ovarian cancer caused by BRCA1 mutations. Eleven clinical cycles were performed, resulting in the birth of an unaffected girl. For one of the couples undergoing PGD for NF2, a spontaneous pregnancy ensued after five unsuccessful PGD cycles. The couple underwent chorionic villus sampling (CVS) and the application of the same protocol as used during PGD showed an unaffected fetus. CONCLUSION: In this work, we present the development and clinical application of PGD for three cancer predisposition syndromes.
Authors: Marion Drüsedau; Jos C Dreesen; Inge Derks-Smeets; Edith Coonen; Ron van Golde; Jannie van Echten-Arends; Peter M M Kastrop; Marinus J Blok; Encarna Gómez-García; Joep P Geraedts; Hubert J Smeets; Christine E de Die-Smulders; Aimée D Paulussen Journal: Eur J Hum Genet Date: 2013-03-27 Impact factor: 4.246
Authors: Akriti Dewanwala; Anu Chittenden; Margery Rosenblatt; Rowena Mercado; Judy E Garber; Sapna Syngal; Elena M Stoffel Journal: Fam Cancer Date: 2011-09 Impact factor: 2.375
Authors: Francesca E Duncan; Jennifer K Jozefik; Alison M Kim; Jennifer Hirshfeld-Cytron; Teresa K Woodruff Journal: US Obstet Gynecol Date: 2011-01-01
Authors: Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier Journal: J Genet Couns Date: 2011-12-02 Impact factor: 2.537
Authors: Qingxue Wang; Judy F C Chow; William S B Yeung; Estella Y L Lau; Vivian C Y Lee; Ernest H Y Ng; Pak-Chung Ho Journal: J Assist Reprod Genet Date: 2014-10-11 Impact factor: 3.412